About US
Contact us
-
BASF raises prices for ethanolamines, ethyleneamines and isopropanolamines in EuropeWith immediate effect, BASF is increasing the sales prices for ethanolamines, ethyleneamines and isopropanolamines in Europe as follows, existing contracts permitting: Ethanolamines: Mon2010/2/5
-
Preserving Europe’s prosperity through innovationAs the national champion of a group of European business leaders, BASF’s boss Dr. Jürgen Hambrecht has spoken up for Europe. “We need to combine our strengths and focus on the sole opportunity that we2010/2/5
-
Assay Development for Immunogenicity Testing of herapeutic Proteins20100204(3).rar2010/2/4
-
Compounding Tamiflu OralSuspension in Advance to Provide for Multiple Prescriptions20100204(2).rar2010/2/4
-
The Use of Mechanical Calibration of Dissolution Apparatus 1 and 2 – Current Good Manufacturing Practice20100204(1).rar2010/2/4
-
Assessment of Abuse Potential of Drugs DRAFT GUIDANCE20100203(3).rar2010/2/3
-
HORIBA Medical launches Pentra C200 compact chemistry analyserHORIBA Medical has launched its new Pentra C200 compact chemistry analyser. Designed as an economical option for smaller sized laboratories, the Pentra C200 incorporates standards usually only found i2010/2/3
-
Aegis Therapeutics Announces Strategic Alliance With Dr. Reddy’s & Phase I Clinical StudyAegis Therapeutics, LLC and Dr. Reddy’s Laboratories recently announced a partnership providing Dr. Reddy’s access to Aegis’ Intravail drug delivery technology for certain undisclosed therapeu2010/2/3
-
Penwest Announces Initiation of Phase IIa Clinical Trial of A0001 in Patients With Friedreich's AtaxiaPenwest Pharmaceuticals Co. recently announced that it initiated a Phase IIa clinical trial for A0001 in December and that the screening of patients is underway. The study is being conducted a2010/2/2
-
Copley Scientific Launches World’s First Commercial Apparatus for Dissolution Testing of Inhaled DrugsCopley Scientific has launched the world’s first commercially available apparatus designed specifically for dissolution testing of inhaled drug formulations. Based on a concept developed by Pr2010/2/2